NYSE$NHC

National HealthCare Corporation · Q1 2021 earnings

Q1 2021 earnings · · Investor relations

Briefing

NHC reported Q1 2021 earnings with a decrease in net operating revenues and CARES Act income but an increase in GAAP net income.

National HealthCare Corporation reported net operating revenues and CARES Act income of $250,973,000 for Q1 2021, a decrease of 2.0% compared to Q1 2020. GAAP net income attributable to NHC was $21,267,000, compared to a net loss of $26,852,000 in the same period of 2020. GAAP diluted earnings per share was $1.38, compared to a diluted loss per share of $1.76 in the same period of 2020.

  • Net operating revenues and CARES Act income totaled $250,973,000, a 2.0% decrease year-over-year.
  • GAAP net income attributable to NHC was $21,267,000, compared to a net loss in the same period last year.
  • GAAP diluted earnings per share was $1.38, compared to a diluted loss per share in the same period last year.
  • Census in skilled nursing facilities increased approximately 3.5% from the beginning of January 2021 through the end of March 2021.

Headline financials

Total Revenue

$251M

Previous: $256M-2.0%
EPS (adj)

$1.08

Previous: $1.11-2.7%
Capital Expenditures

-$4.33M

Previous: -$6.63M+34.7%
Free Cash Flow

$16.9M

Previous: -$33.5M+150.6%
Net Income

$21.3M

Previous: -$26.9M+179.2%
Operating Income

$15.2M

Previous: $15.8M-3.7%
Gross Profit

$251M

Previous: $256M-2.0%
Cash & Equivalents

$134M

Previous: $69.5M+93.0%
Total Assets

$1.36B

Previous: $1.26B+7.9%
Stock-Based Comp

$496K

Previous: $466K+6.4%

Revenue & EPS history

NHC · Revenue · Quarterly

$251M

Q1 2021-2%vs Q1 2020

Revenue by segment

NHC · $241M total across 2 segments · Q1 2021

  • Net patient revenues
    $226M
  • Other revenues
    $14.6M

Forward guidance

Forward-looking statements involve risks and uncertainties detailed in NHC's filings with the SEC.

Headwinds

  • Liabilities and other claims asserted against us and patient care liabilities, as well as the resolution of current litigation
  • Availability of insurance and assets for indemnification
  • National and local economic conditions; including their effect on the availability and cost of labor, utilities and materials
  • The effect of government regulations and changes in regulations governing the healthcare industry, including our compliance with such regulations
  • Changes in Medicare and Medicaid payment levels and methodologies and the application of such methodologies by the government and its fiscal intermediaries

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2021

Historical avgQ1 2021

+0.1%

Avg return

Earnings day

+1.7%

Avg return

5 days after

+1.8%

Avg return

30 days after

60%

39 / 65 earnings

Positive

+12.2%

Q2 2023

Best reaction

-14.0%

Q4 2009

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+0.8%+11.8%+12.9%
Q4 2025+2.0%-4.7%-3.7%
Q3 2025+1.1%+3.4%+7.8%
Q1 2025+1.6%-3.1%-3.3%
Q4 2024+0.8%+0.1%-0.2%
Q3 2024+4.5%-0.1%-4.8%
Q2 2024+3.2%+3.7%+6.4%
Q1 2024+0.9%+4.4%+7.4%
Q4 2023+5.8%+7.1%-0.1%
Q3 2023+1.8%+3.9%+14.2%
Q2 2023+12.2%+12.6%+12.5%
Q1 2023+1.9%+5.4%+11.5%
Q4 2022-2.4%-3.9%-8.2%
Q3 2022-3.2%-1.0%-1.3%
Q2 2022+1.1%+1.9%+0.8%
Q1 2022+2.8%+0.8%+1.9%
Q4 2021+0.5%+0.4%+9.6%
Q3 2021+5.9%+1.3%-10.0%
Q2 2021-0.8%-2.4%-5.9%
Q1 2021-1.5%-1.6%+2.4%
Q4 2020+3.7%+10.3%+20.5%
Q3 2020-1.8%+13.0%+2.3%
Q2 2020+5.8%+5.0%-1.2%
Q1 2020-0.0%-5.0%+5.4%
Q4 2019-0.2%-8.4%-16.6%
Q3 2019-0.4%+0.1%+1.1%
Q2 2019-0.6%+0.4%-5.3%
Q1 2019+0.1%+1.4%+2.3%
Q4 2018+1.8%-0.2%-4.2%
Q3 2018-2.3%-3.5%-2.1%
Q2 2018+1.7%+4.4%+5.3%
Q1 2018+3.0%+3.8%+8.3%
Q4 2017-7.1%-2.5%-3.3%
Q3 2017-1.0%+2.9%+0.4%
Q2 2017+0.0%+2.3%-3.8%
Q1 2017-1.1%-1.2%-2.2%
Q4 2016+1.0%+0.8%+0.3%
Q3 2016-2.1%+1.0%+7.6%
Q2 2016+1.9%+2.6%+4.7%
Q1 2016-0.6%
Q4 2015-1.6%
Q3 2015+0.5%
Q2 2015-3.4%
Q1 2015+0.1%
Q4 2014+1.0%
Q3 2014+1.9%
Q2 2014+0.4%
Q1 2014+2.3%
Q4 2013-0.4%
Q3 2013+0.7%
Q2 2013+1.5%
Q1 2013-0.3%
Q4 2012+1.2%
Q3 2012+1.8%
Q2 2012-1.0%
Q1 2011-4.9%
Q1 2012+3.2%
Q4 2011-0.9%
Q3 2010+7.9%
Q3 2011+7.9%
Q4 2009-14.0%
Q4 2010-14.0%
Q2 2010-14.0%
Q2 2011-14.0%
Q1 2010+3.5%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro